Перевести на Переведено сервисом «Яндекс.Перевод»

Pernix Therapeutics Holdings

Страна
USA
Краткое название
Pernix Therapeutics Holdings
Штаб квартира
10003 Woodloch Forest Drive
Члены правления

Cooper C. Collins,
President and Chief Executive Officer
David Becker,
Chief Financial Officer
Michael Venters,
Vice President of Corporate Development
Tracy S. Clifford,
Corporate Controller and Director of Finance
Beth Bonner DeVille,
Vice President of Sales Training & Compliance
Joseph T. Schepers,
Director of Investor Relations and Corporate Communications
Robert H. Cline, Jr.,
Pharm D., Vice President of Supply Chain Management
Shawn M. Dol,
National Sales Director, Pediatric Division
Brandon R. Belanger,
National Sales Director, Gastroenterology Division
Jamison V. Roberts,
Director of Government Affairs
Leslie White,
Director of Regulatory Affairs & Quality Assurance

Разделы медицины
Детские болезни (Педиатрия)
Стадия проекта
Производство
Заболевания
Болезни органов дыхания, Лихорадка и гипертермия
Тикер
PTX
Текущие владельцы

Michael C. Pearce,
Chairman of the Board of Directors
Cooper C. Collins,
Anthem Hayek Blanchard
James E. Smith, Jr.,
Steven A. Elms

Объем фонда
230.7600
Технологии
Другое, Фармацевтика, Химия